Bruce G. Pollock

Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases

Assessing Motor Cortex Excitability and Its Relationship with Cortical Atrophy in Alzheimer’s Dementia

Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment

Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study

White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases

Assessing motor cortex excitability and it's relationship with cortical atrophy in Alzheimer's dementia

Assessing motor cortex excitability and its relationship with brain atrophy in Ahlzeimer’s disease

White Matter Hyperintensities and Cortical Atrophy are associated with Neuropsychiatric Symptoms in Neurodegenerative and Cerebrovascular Diseases

Escitalopram for agitation in Alzheimer's disease (S‐CitAD): Methods and design of an investigator‐initiated, randomized, controlled, multicenter clinical trial

GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder

R‐ and S‐citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation

Amyloid deposition in semantic dementia: a positron emission tomography study

Preclinical target validation using patient-derived cells

Effect of Citalopram on Agitation in Alzheimer Disease

Dopamine D2/3 occupancy of ziprasidone across a day: a within-subject PET study